AI THERAPEUTICS
Dead / Abandoned — Abandoned — no statement of use filed (as of 20 Mar 2023)
What this means for you
This application is over — abandoned 20 Mar 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88238864
- Mark type
- Design + words
- Filed
- 21 Dec 2018
- Published for opposition
- 17 Dec 2019
- Abandoned
- 20 Mar 2023
- Attorney of record
- Christina M. Licursi, Esq.
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical and biopharmaceutical agents for the treatment of cancer and rare diseases; pharmaceutical and biopharmaceutical preparations and substances for the treatment of cancer and rare diseases
- Class 042 — Scientific and technological services: Pharmaceutical, medical, scientific, and biopharmaceutical research and development; medical and scientific research in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, and genetic diseases
Owner
- AI Therapeutics, Inc., Guilford, CT, US
- AI Therapeutics, Inc., Guilford, CT, US
Prosecution history
- 20 Mar 2023 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 20 Mar 2023 — ABANDONMENT - NO USE STATEMENT FILED
- 13 Aug 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Aug 2022 — SOU EXTENSION 5 GRANTED
- 04 Aug 2022 — SOU EXTENSION 5 FILED
- 12 Aug 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 04 Aug 2022 — SOU TEAS EXTENSION RECEIVED
- 10 Feb 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Feb 2022 — SOU EXTENSION 4 GRANTED
- 08 Feb 2022 — SOU EXTENSION 4 FILED
- 08 Feb 2022 — SOU TEAS EXTENSION RECEIVED
- 11 Aug 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Aug 2021 — SOU EXTENSION 3 GRANTED
- 09 Aug 2021 — SOU EXTENSION 3 FILED
- 09 Aug 2021 — SOU TEAS EXTENSION RECEIVED